Charles River Laboratories International, Inc.

NYSE:CRL

Sector

🏥 Health Care

Industries

🔬 Clinical Trials

🧬 Biotechnology

Location

United States

Market Cap

USD 8.69 B

Share Price

USD 176.93

Avg Daily Volume

1,537,950

Change (1 day)

-0.10%

Change (1 year)

-20.23%

Change (YTD)

-4.15%

Charles River Laboratories International, Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending March 29, 2025: USD 742.51 M

Charles River Laboratories International, Inc. Selling, General, and Administrative Expenses (SG&A) is USD 742.51 M for the Trailing 12 Months (TTM) ending March 29, 2025, a -2.21% change year over year. Selling, general, and administrative (SG&A) expenses are the expenses related to the sales and marketing efforts, as well as general and administrative functions of a company.

Charles River Laboratories International, Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending March 30, 2024 was USD 759.30 M, a 10.37% change year over year.
Charles River Laboratories International, Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending April 01, 2023 was USD 687.98 M, a 12.01% change year over year.
Charles River Laboratories International, Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending March 26, 2022 was USD 614.22 M, a 10.72% change year over year.
Charles River Laboratories International, Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending March 27, 2021 was USD 554.77 M, a 5.68% change year over year.